牛牛AI助理已提取核心訊息
Michael Robert A., an officer at AbbVie Inc., is set to sell 68,879 shares of the company's common stock, with an aggregate market value of approximately $12.15 million, on February 29, 2024. The shares to be sold were acquired through stock option exercises and performance shares, both as part of compensation from the issuer. On February 29, 2024, Michael Robert A. exercised stock options to acquire 21,560 shares, and on February 28, 2024, he acquired 47,319 shares through performance shares. There is no transaction history reported for the past three months prior to this notice.
Michael Robert A., an officer at AbbVie Inc., is set to sell 68,879 shares of the company's common stock, with an aggregate market value of approximately $12.15 million, on February 29, 2024. The shares to be sold were acquired through stock option exercises and performance shares, both as part of compensation from the issuer. On February 29, 2024, Michael Robert A. exercised stock options to acquire 21,560 shares, and on February 28, 2024, he acquired 47,319 shares through performance shares. There is no transaction history reported for the past three months prior to this notice.
艾伯維公司高管邁克爾·羅伯特·A定於2024年2月29日出售該公司68,879股普通股，總市值約爲1,215萬美元。待售股票是通過股票期權行使和績效股票收購的，兩者都是發行人薪酬的一部分。2024年2月29日，邁克爾·羅伯特·A行使股票期權收購了21,560股股票；2024年2月28日，他通過績效股票收購了47,319股股票。在此通知之前的過去三個月中，沒有報告任何交易歷史記錄。
艾伯維公司高管邁克爾·羅伯特·A定於2024年2月29日出售該公司68,879股普通股，總市值約爲1,215萬美元。待售股票是通過股票期權行使和績效股票收購的，兩者都是發行人薪酬的一部分。2024年2月29日，邁克爾·羅伯特·A行使股票期權收購了21,560股股票；2024年2月28日，他通過績效股票收購了47,319股股票。在此通知之前的過去三個月中，沒有報告任何交易歷史記錄。
有用
沒用